Pharmaceuticals Global On demand · 24-48h

Global Empty Capsules Market Strategic Research Report

Global Empty Capsules Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Empty Capsules Market
$3.59B2025
7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Gelatin Empty Hard Capsules, HPMC Vegetable Hard Capsules, Pullulan Polysaccharide Hard Capsules

By Application: Pharmaceutical Capsules, Nutraceuticals Capsules, Traditional Medicine Capsules, Cosmetic Powder Encapsulation Capsules, Veterinary Medicines

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Lonza (Capsugel), ACG Group, Qualicaps, Suheung Co., Ltd., CapsCanada, Catalent, Inc., Lefancaps, Erawat Pharma Limited, Sunil Healthcare Ltd., Shanxi Guangsheng Capsule Co., Ltd., Anhui Huangshan Capsule Co., Ltd., Shandong Healsee Capsule Ltd., Zhejiang Er-Kang Capsule Co., Ltd., Medicaps Ltd., Farmacapsulas S.A., Dah Feng Capsule Co., Ltd., Natural Capsules Limited, Meihua Group

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 142 pages
Market size 2025
$3.59B
Billion USD
Forecast CAGR
7%
2025-2032
Forecast 2032
$5.8B
Projected
영역들
5
Asia Pacific · Latin America · MEA · Europe · North America

개요

Scope of the Report

The global Empty Capsules market size is predicted to grow from US$ 3,590 million in 2025 to US$ 5,738 million in 2032; it is expected to grow at a CAGR of 7.0% from 2026 to 2032.

An empty capsule is a bottle-shaped or sleeve-shaped container made of film-forming materials, with specific shapes and sizes, and is specially used for filling various drugs or health supplements. Its upstream supply chain mainly consists of manufacturers of capsule materials such as high-purity pharmaceutical-grade gelatin, hydroxypropyl methylcellulose, and pullulan dextrin, as well as suppliers of antioxidants and colorants; its downstream supply chain is vertically connected to global large pharmaceutical enterprises, health supplement processing factories, and research and clinical institutions. In the manufacturing process, industry barriers mainly focus on high-precision impregnation molding technology and moisture content control technology. According to global core industrial data, the global average market price of empty capsules is $2.3 per 10,000 capsules. In terms of sales volume and production capacity, the global annual total sales reach 980 billion capsules, the global nominal production capacity is 125 billion capsules, and the industry average gross profit margin is 28%, and the net profit margin is 11%.

The demand for the precision of dosage forms in the global pharmaceutical market is driving the empty capsule industry to rapidly transform towards vegetarianization and functionalization. In terms of future trends, non-animal-derived capsule materials are replacing traditional gelatin capsules at a rate of over 20% per year to meet the demands of vegetarianism, religious dietary restrictions, and the avoidance of animal-derived diseases worldwide; at the same time, enteric-coated capsules that can precisely control the disintegration site, colon-targeted release capsules, and special capsules developed for inhalation agents are becoming the focus of high-end research and development. In terms of driving factors, on one hand, the increase in the global elderly population base leads to a continuous increase in the dosage of chronic disease medications, and capsule formulations, due to their easy swallowing and odor-masking characteristics, have become the preferred choice for elderly patients; on the other hand, the explosive growth of the health management market has led to the large-scale adoption of plant empty capsules with low water content as carriers for various water-sensitive natural ingredients such as plant extracts and probiotics.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Empty Capsules market?

What factors are driving Empty Capsules market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Empty Capsules market opportunities vary by end market size?

How does Empty Capsules break out by Type, by Application?

This report presents a comprehensive overview of the global Empty Capsules market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Gelatin Empty Hard Capsules
  • HPMC Vegetable Hard Capsules
  • Pullulan Polysaccharide Hard Capsules

Segment by Release

  • Immediate Release Hard Capsules
  • Enteric Soluble Hard Capsules
  • Colon Targeted Hard Capsules

Segment by Size

  • Standard Size Zero Capsules
  • Standard Size One to Three Capsules
  • Mini Size Four to Five Capsules

Segment by Application

  • Pharmaceutical Capsules
  • Nutraceuticals Capsules
  • Traditional Medicine Capsules
  • Cosmetic Powder Encapsulation Capsules
  • Veterinary Medicines

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Empty Capsules market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Pharmaceutical Capsules, Nutraceuticals Capsules, Traditional Medicine Capsules evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Empty Capsules Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$3.59B
2025
Forecast
$5.8B
2032
CAGR
7%
2025–2032
영역들
5
global
Key companies
Lonza (Capsugel)ACG GroupQualicapsSuheung Co., Ltd.CapsCanadaCatalent, Inc.LefancapsErawat Pharma Limited
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Gelatin Empty Hard CapsulesHPMC Vegetable Hard CapsulesPullulan Polysaccharide Hard Capsules
By Application
Pharmaceutical CapsulesNutraceuticals CapsulesTraditional Medicine CapsulesCosmetic Powder Encapsulation CapsulesVeterinary Medicines

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Gelatin Empty Hard Capsules
  • 3.1.3 HPMC Vegetable Hard Capsules
  • 3.1.4 Pullulan Polysaccharide Hard Capsules
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Pharmaceutical Capsules
  • 4.1.3 Nutraceuticals Capsules
  • 4.1.4 Traditional Medicine Capsules
  • 4.1.5 Cosmetic Powder Encapsulation Capsules
  • 4.1.6 Veterinary Medicines
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Lonza (Capsugel)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 ACG Group
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Qualicaps
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Suheung Co., Ltd.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 CapsCanada
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Catalent, Inc.
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Lefancaps
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Erawat Pharma Limited
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Sunil Healthcare Ltd.
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Shanxi Guangsheng Capsule Co., Ltd.
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Anhui Huangshan Capsule Co., Ltd.
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Shandong Healsee Capsule Ltd.
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Zhejiang Er-Kang Capsule Co., Ltd.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Medicaps Ltd.
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Farmacapsulas S.A.
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Dah Feng Capsule Co., Ltd.
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Natural Capsules Limited
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Meihua Group
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Empty Capsules market?
The global Empty Capsules market is estimated at US$ 3.59 billion in 2025 (base year) and is projected to reach US$ 5.74 billion by 2032.
How fast is the Empty Capsules market expected to grow?
The market is expected to grow at a CAGR of 7.0% from 2026 to 2032, expanding from US$ 3.59 billion in 2025 to US$ 5.74 billion in 2032, roughly 1.6 times its base-year value.
What does the Empty Capsules market cover?
An empty capsule is a bottle-shaped or sleeve-shaped container made of film-forming materials, with specific shapes and sizes, and is specially used for filling various drugs or health supplements. In the manufacturing process, industry barriers mainly focus on high-precision impregnation molding technology and moisture content control technology.
How is the Empty Capsules market segmented by type?
By type, the market is segmented into Gelatin Empty Hard Capsules, HPMC Vegetable Hard Capsules and Pullulan Polysaccharide Hard Capsules.
What are the key applications of Empty Capsules?
Key applications covered include Pharmaceutical Capsules, Nutraceuticals Capsules, Traditional Medicine Capsules, Cosmetic Powder Encapsulation Capsules and Veterinary Medicines.
Which companies are profiled in the Empty Capsules market report?
Key players profiled include Lonza (Capsugel), ACG Group, Qualicaps, Suheung Co., CapsCanada, Catalent, Lefancaps and Erawat Pharma Limited, among 18 companies covered in total.
What geographies does the Empty Capsules market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Empty Capsules?
The demand for the precision of dosage forms in the global pharmaceutical market is driving the empty capsule industry to rapidly transform towards vegetarianization and functionalization.
What are the main risks and barriers in the Empty Capsules market?
In the manufacturing process, industry barriers mainly focus on high-precision impregnation molding technology and moisture content control technology.
Who should buy the Empty Capsules market report?
The report is intended for manufacturers and solution providers, distributors and end users in Pharmaceutical Capsules, Nutraceuticals Capsules and Traditional Medicine Capsules, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Empty Capsules market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.